JOURNAL OF COSMETIC SCIENCE 196 actinic eye disease prevention trial: design and baseline characteristics of participants, Contr. Clin. Trials, 15, 512–522 (1994). (7) A. Green, D. Battistutta, V. Hart, D. Leslie, D. Weedon The Nambour Study Group, Skin cancer in a subtropical Australian population: incidence and lack of association with occupation, Am. J. Epidemiol., 144, 1034–1040 (1996). (8) A. Green, G. Williams, R. Neale, V. Hart, D. Leslie, P. Parsons, G. C. Marks, P. Gaffney, D. Battistutta, C. Frost, C. Lang, and A. Russell, Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial, Lancet, 354, 723–729 (1999a). (9) J. C. van der Pols, G. M. Williams, N. Pandeya, V. Logan, and A. C. Green, Prolonged prevention of squamous cell carcinoma of the skin with regular sunscreen use, Cancer Epidemiol. Biomark. Pre., 15, 2546–2548 (2006a). (10) A. C. Green, G. M. Williams, V. Logan, and G. M. Strutton, Reduced melanoma after regular sunscreen use: randomized trial follow-up, J. Clin. Oncol., 29, 257–263 (2011). (11) A. Green, G. Williams, R. Neale, and D. Battistutta, Betacarotene and sunscreen use: author’s reply, Lancet, 354, 2163–2164 (1999b). (12) J. C. van der Pols, G. M. Williams, R. E. Neale, A. Clavarino, and A. C. Green, Long-term increase in sunscreen use in an Australian community after a skin cancer prevention trial, Prev. Med., 42, 171–176 (2006b). (13) Pandeya N., Purdie D., Green A. C., and Williams G., Repeated occurrences of basal cell carcinoma of the skin and multi-failure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial, Am. J. Epidemiol., 161, 748–754 (2005). (14) N. Jayaratne, A. Russell, and J. C. van der Pols, Sun protection and vitamin D status in an Australian subtropical community, Prev. Med., 55, 146–150 (2012). (15) A. R. Lindstrom, L. A. von Schuckmann, M. C. B. Hughes, G. M. Williams, A. C Green, and J. C. van der Pols, Regular sunscreen use and risk of mortality: long-term follow-up of a skin cancer prevention trial, Am. J. Prev. Med., 56, 742–746 (2019). (16) R. Neale, G. Williams, and A. Green, Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial, Arch. Dermatol., 138, 1319–1325 (2002). (17) S. C. .Thompson, D. Jolley, and R. Marks, Reduction of solar keratoses by regular sunscreen use, N. Engl. J. Med., 329, 1147–1151 (1993). (18) M. F. Naylor, A. Boyd, D. W Smith, G. S. Cameron, D. Hubbard, and K. H. Neldner, High sun protec- tion factor sunscreens in the suppression of actinic neoplasia, Arch. Dermatol., 131, 170–175 (1995). (19) S. Darlington, G. Williams, R. Neale, C. Frost, and A. Green, A randomized controlled trial to assess sunscreen application and betacarotene supplementation in the prevention of solar keratosis, Arch. Der- matol., 139, 451–455 (2003). (20) T. K. Lee, J. K. Rivers, and R. P. Gallagher, Site-specifi c protective effect of broad-spectrum sunscreen on nevus development among white schoolchildren in a randomized trial, J. Am. Acad. Dermatol., 52, 786–792 (2005). (21) A. C. Green, Epidemiology of actinic keratosis, Curr. Probl. Dermatol., 46, 1–7 (2015). (22) C. M. Olsen, H. J. Carroll, and D. C. Whiteman, Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma, Canc. Prev. Res., 3, 233–245 (2010). (23) C. M. Olsen, L. F. Wilson, A. C. Green, N. Biswas, J. Loyalka, and D. C. Whiteman, Prevention of DNA damage in human skin by topical sunscreens, Photodermatol. Photoimmunol. Photomed., 33, 135–142 (2017).
Previous Page Next Page